Socialiya - Entertainment. Knowledge. Community.
Why This Biotech Plummeted Despite Its 'Best-Case' Study

Abivax (ABVX) stock crashed by more than a third Tuesday despite what one analyst called "best-case"...

BUSINESS NEWS June 02, 2026

Why This Biotech Plummeted Despite Its 'Best-Case' Study

Abivax (ABVX) stock crashed by more than a third Tuesday despite what one analyst called "best-case" results for a study of its ulcerative colitis treatment...

2 views 0 likes 0 comments
Share:
Abivax (ABVX) stock crashed by more than a third Tuesday despite what one analyst called "best-case" results for a study of its ulcerative colitis treatment...

Author: Investor's Business Daily

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya